Tag: diabetes mellitus

July 3, 2018

4 Top Biotech Stocks on the TSX of Q2 2018

Which biotech stocks on the TSX have performed the best year-to-date? These four companies have risen to the top of...
April 12, 2018

Vascepa® (Icosapent Ethyl) Showed Reductions in Potentially Atherogenic Lipid and Inflammatory Markers in Statin-Treated Patients with Reduced Kidney Function and Persistent High Triglycerides

Amarin Corporation (NASDAQ:AMRN), a biopharmaceutical company focused on the commercialization and development of therapeutics to improve cardiovascular (CV) health, announced the...
March 26, 2018

Lexicon Pharmaceuticals Announces Regulatory Submissions for Sotagliflozin to Treat Adults With Type 1 Diabetes

Lexicon Pharmaceuticals (Nasdaq:LXRX) announced that its collaborator, Sanofi, has submitted a New Drug Application (NDA) to the U.S. Food and Drug...
January 30, 2018

5 Top Biotech Stocks to Watch on the TSX in 2018

Whether you've been interested in biotech companies for a while, or just getting in the business, these companies are ones...
July 25, 2017

AntriaBio Announces First Patient Dosed in Clinical Study

AntriaBio announced the dosing of the first patient in their Phase 1 first-in-human clinical trial of its lead product candidate,...
July 10, 2017

Resverlogix Randomizes First Patient in Phase 3 Trial

Resverlogix announced the randomization of the first patient in its Taiwanese Phase 3 clinical trial with their lead drug apabetalone.
June 5, 2017

AntriaBio Files Investigational NDA for AB101

AntriaBio filed an Investigational New Drug application with the FDA for their basal insulin treatment for diabetes mellitus patients. A...